Firm Record

TJP Labs Inc. findings history

46 findings from 6 inspection documents published by regulators. Each row below says what its date means.

Health Canada 2022-04-27 ~ 2025-12-16 6 documents 46 findings

Areas cited

Material and supplier controlOther quality systemStability and storageEquipment and facilityComputer system validationRegulatory reporting and change controlCleaning validationLaboratory and QC controlsLabeling and packagingDocumentation and recordsValidation and qualificationContamination controlDeviation, CAPA, and investigation

Published inspection documents

2025-12-16 Health Canada 3 findingsOther quality system The recorded information or details were inadequate. 2025-01-13 Health Canada 13 findingsMaterial and supplier control · Computer system validation · Deviation, CAPA, and investigation · Other quality system · Cleaning validation · Equipment and facility · Laboratory and QC controls Each container of a lot of raw materials was not tested to identify its contents with a specific, discriminating test. The sampling plan for raw materials was inadequate. A sample from each lot of raw materials was not fully tested against the specifications. 2023-10-18 Health Canada 8 findingsStability and storage · Material and supplier control · Cleaning validation · Validation and qualification · Regulatory reporting and change control · Computer system validation The evidence used to demonstrate the transportation and/or storage conditions of each lot or batch of the drug was inadequate. The temperature and/or humidity control was inadequate. 2023-05-02 Health Canada 13 findingsEquipment and facility · Labeling and packaging · Material and supplier control · Laboratory and QC controls · Contamination control · Stability and storage · Other quality system · Computer system validation · Documentation and records · Regulatory reporting and change control The maintenance of records was inadequate. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate. 2022-11-02 Health Canada 3 findingsLabeling and packaging · Stability and storage · Material and supplier control The importer did not ensure that the foreign sites use to fabricate, package/label, or test drug products met the requirements described in Guidance on Evidence to Demonstrate Drug GMP Compliance of Foreign Sites (GUI-0080). 2022-04-27 Health Canada 6 findingsStability and storage · Material and supplier control · Other quality system · Equipment and facility For imported products, the stability studies from foreign sites were not compliant with Canadian good manufacturing practices and/or Canadian marketing authorization.

About this page

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

What is included. As of 2026-09-03, only documents that have a detail page (at least 3 findings) are listed. The company may have more documents; the full set is available in Company lookup below.

Companies are grouped by a normalised key, not the displayed name — “… Limited” and “… Ltd.” count as the same company. Translation and classification are automated and may differ in nuance from the source; the basis for judgement is always the regulator's published document.

Full history of TJP Labs Inc. — including inspection classifications Browse by document Go to Findings search